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OBJECTIVES The purpose of this study was to examine the circadian variation of ventricular arrhythmias
detected by an implantable cardioverter defibrillator in patients with and without ischemic
heart disease.
BACKGROUND Previous studies have shown a circadian variation of ventricular arrhythmias, sudden death
and myocardial infarction with a peak occurrence in the morning hours. The circadian
pattern, which is similar for both arrhythmic and ischemic events, suggests that ischemia may
play a critical role in the genesis of ventricular arrhythmias and sudden death. We
hypothesized that, if ischemia plays an important role in the triggering of ventricular
arrhythmias, the circadian pattern should be different in patients with ischemic heart disease
compared with patients with nonischemic heart disease.
METHODS The circadian variation of ventricular arrhythmias recorded by an implantable cardioverter
defibrillator was studied in 310 patients during a mean follow-up of 181 6 163 days. Two
hundred four patients had a history of ischemic heart disease and 106 patients had
nonischemic heart disease. The times of the episodes of ventricular arrhythmias were retrieved
from the data log of each device during follow-up, and the circadian pattern was compared
between the two groups.
RESULTS During follow-up, 1,061 episodes of ventricular arrhythmias were recorded by the device in
the 310 patients. Six hundred eighty-two episodes occurred in the group of patients with
ischemic heart disease and 379 occurred in the nonischemic heart disease group. The
circadian variation of the episodes showed a typical pattern with a morning and afternoon
peak in both groups of patients with ischemic and nonischemic heart disease, but there was
no significant difference between the two groups.
CONCLUSIONS The circadian rhythm of ventricular arrhythmias in patients with ischemic heart disease is
similar to patients with nonischemic heart disease, suggesting that the trigger mechanisms of
the initiation of ventricular tachyarrhythmias may be similar, irrespective of the underlying
heart disease. (J Am Coll Cardiol 1999;34:1560–8) © 1999 by the American College of
Cardiology
A circadian variation of ischemic events, ventricular ar-
rhythmias and sudden death is a well recognized phenom-
enon in patients with ischemic heart disease (1–9). Arrhyth-
mic events show a similar circadian pattern as ischemic
events, suggesting that ischemia may play a critical role in
the genesis of ventricular arrhythmias and sudden death.
Most previous studies on the circadian pattern of sudden
death and cardiac arrhythmias have used information from
interviews of witnesses, death certificates and 24-h ambu-
latory electrocardiogram (ECG) recordings (1–3,10–13).
Recently, more accurate information with the exact timing
of these events has become available by using information
from implantable cardioverter defibrillators (14–18). A
circadian distribution was found in all studies and was
independent of age, gender and left ventricular (LV) func-
tion. Because most of the patients in these studies had a
history of ischemic heart disease, it is possible that the
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circadian variation in ventricular arrhythmias and delivered
therapy merely reflects a variation in ischemic events in
these patients.
The aim of our study was to delineate the effect of
ischemia on the triggering of ventricular arrhythmias by
comparing the circadian variation in ventricular arrhythmias
in a group of patients with a history of ischemic heart
disease to patients with nonischemic heart disease, who all
were fitted with an implantable cardioverter defibrillator
owing to malignant ventricular arrhythmias, or aborted
sudden death, or both. We hypothesized that, if ischemia
plays an important role in the triggering of ventricular
arrhythmias, the circadian pattern should be different in the
two groups.
METHODS
Patients. This analysis was based on data from the clinical
trial of the Medtronic (Minneapolis, Minnesota) 7219
device (19). Between March 1993 and October 1994, 820
patients were included in 66 European centers. The patients
were characterized by the investigators with regard to
demographic data, underlying heart disease, ejection frac-
tion, documented arrhythmias before implant and indica-
tion for implant.
All patients were followed up at regular visits at one and
three months after the implant and every six months
thereafter, and as clinically indicated to evaluate suspected
arrhythmic events. At each visit, complete interrogation of
the device was performed, which included retrieving data for
all available episodes with a printout.
Implantable cardioverter defibrillators. The technical
characteristics of the device used (Medtronic 7219 C and D)
included 0.4 to 34 J defibrillation/cardioversion shocks and
antitachycardia pacing (Burst, Ramp or Ramp1). A trans-
venous approach was used for all new implants (n 5 778).
Standard surgical and electrophysiologic testing procedures
were used at implant. All patients underwent a predischarge
testing three to seven days after implantation during which
ventricular fibrillation was induced. The device uses an
automatically adjusting electrogram detection threshold,
designed to avoid oversensing of signals such as T waves but
to be sensitive enough to detect low amplitude signals such
as in ventricular fibrillation.
The device is noncommitted, allowing therapy to be
diverted if the arrhythmia terminates spontaneously. All
delivered therapies were classified by the investigator as
appropriate or inappropriate based on the configuration and
stability of the intracardiac ECG, RR interval analysis and
symptoms before or during delivered therapy. Only appro-
priate episodes were included in this analysis.
The device has retrievable data-logging capabilities, with
information regarding the time and date for episodes
fulfilling the detection criteria as well as the cycle length and
response to therapy. A 5-s electrogram storage of the
episode together with the corresponding marker channel are
also available. The total number of episodes can be retrieved
by event counters, but information regarding time and date
cannot be obtained for those episodes preceding the five
most recent episodes.
The time and date of the stored episodes were calculated
from the time settings of the programmer. The program-
mers were set to the correct local time at each center at
implantation and during follow-up and were adjusted for
changes in daylight settings in summer and winter.
The programming of the device was left to the discretion
of each investigator. The study was approved in all investi-
gational centers by the local Ethics Committee, and all
patients enrolled in the study gave their written informed
consent.
Statistics. The circadian distribution of episodes and
storms (defined as at least two episodes of ventricular
arrhythmias occurring within a 10-min period but at least
1 min apart, respectively) was estimated in each individual
patient. This was done by dividing the number of episodes
and storms for each hour of day by the total number of this
patient. The resulting individual distributions are referred to
as “weighted frequencies,” because single episodes are
downweighted by the reciprocal of the total number of
episodes in each patient. With this weighting method, an
overrepresentation of patients with frequent episodes is
avoided.
The mean weighted frequencies of episodes and storms
for each group of patients (ischemic/nonischemic) were
superimposed by the best-fitted third-order harmonic.
Third-order harmonics were chosen because lower order
harmonics did not fit the data well.
We restricted our inferential analyses generally to tables
with patients as sampling units, taking into account only
first episodes or variables that sum up over repeated epi-
sodes. Two types of contingency tables were constructed. In
both types, the two columns represent patient groups
(ischemic/nonischemic) whereas the rows represent hourly
intervals (type I) or 4-h intervals (type II). Four-hour
intervals (beginning with the interval 0 h to 4 h) were
chosen because they correspond well to third-order har-
monics that divide the day into six equal-sized intervals. To
compare the circadian patterns between groups for each cell
of a table in a first step, a configuration frequency analysis
was performed (20–23). Subsequently, a Bonferroni-Holm
sequential rejection procedure (20,24) was applied for each
table to keep a multiple significance level of 0.05.
Although configuration frequency analysis addresses sin-
gular differences at certain time intervals of day, log linear
and logistic regression modeling address overall perfor-
mance (25). Therefore, in a second step, we performed
logistic regression analyses with the subgroup indicator
“ischemia” as dependent variable and the 1-h or 4-h time
intervals as independent categoric variables.
The advantage of the regression approach is that it can be
extended easily to further variables that aggregate the
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information from subsequent episodes. We used this advan-
tage, and, in a third step, fitted logistic models that included
as independent variables the individual percentages of epi-
sodes (storms) occurring in selected 4-h intervals.
RESULTS
Of the 820 patients who had an implantable cardioverter
defibrillator during the study period, 310 had one or more
episodes of appropriately detected ventricular arrhythmias.
In these patients, a total of 3,704 episodes were recorded by
the event counters. Fourteen hundred thirty-eight episodes
were recorded as the last five episodes and, hence, full
information, including the intracardiac ECG, marker chan-
nel, date and time of these episodes was available. The
remaining 2,266 episodes, for which no such information
was stored, appeared in 116 patients. In 88 patients, .50%
of the episodes were recorded by event counters only.
The mean (6 SD) age of the study population of the 310
patients in which ventricular arrhythmias were detected was
58 6 13 years. Two hundred sixty-two patients were men
(85%). Two hundred four patients (66%) had a history of
ischemic heart disease, of whom 171 had a previous myo-
cardial infarction. The remaining 106 patients were classi-
fied as having nonischemic heart disease: dilated cardiomy-
opathy (n 5 59), hypertrophic cardiomyopathy (n 5 7), RV
dysplasia (n 5 10), long QT syndrome (n 5 3), valvular
heart disease including mitral valve prolapse (n 5 12) or
primary electrical disease (n 5 15).
Table 1 shows the demographic and electrophysiologic
characteristics of the patients with and without ischemic
heart disease. Patients with ischemic heart disease were
older, more often male, had a lower ejection fraction and
more often belonged to NYHA class II to III. The
indication for implant and documented ventricular arrhyth-
mias prior to implant did not differ between the two groups.
Three hundred ninety-three episodes occurred during beta-
adrenergic blocking agent therapy, including sotalol. This
was recorded in a total of 106 patients, 66 (32%) with
ischemic heart disease and 40 (38%) without (NS).
Episodes during follow up. During a mean follow up of
181 6 163 days (range 4 to 625 days), a total of 1,438
appropriate episodes were recorded in the 310 patients who
Table 1. Demographic and Electrophysiologic Characteristics of Patients With and Without
Ischemic Heart Disease
IHD
n 5 204
Non-IHD
n 5 106
p
Value
Age, mean 6 SEM 61 6 0.8 52 6 1.2 , 0.01
Gender 180/24 82/24 , 0.05
Ejection fraction (mean 6 SEM) 35 6 1.1 46 6 1.5 , 0.01
NYHA
I (%) 11 41
II (%) 67 41 , 0.01
III–IV (%) 22 17
Previous PTCA or CABG (%) 33 0 , 0.01
Indication for implant
Ventricular arrhythmias (%) 65 58 NS
Aborted sudden death (%) 48 47 NS
Both (%) 17 10 NS
Other (%) 5 6 NS
Documented ventricular arrhythmias before implant
Ventricular tachycardia (%) 63 53 0.09
Ventricular fibrillation (%) 42 39 NS
VT 1 VF (%) 15 7
No documented ventricular arrhythmia (%) 9 15 , 0.05
No. of episodes ,6 mo to implant, mean (range) 2.8 6 0.07 2.8 6 0.10 NS
(1–5) (1–5)
Patients with .2 episodes ,6 mo (%) 62 54 NS
Pharmacologic treatment at hospital discharge (%)
Amiodarone (%) 9 8 NS
Beta-blocker (%) 18 15 NS
Sotalol (%) 17 14 NS
Class 1 antiarrhythmic agent (%) 5 6 NS
Calcium-channel blocker (%) 4 7 NS
Digitalis (%) 29 20 NS
Angiotensin-converting enzyme inhibitor (%) 48 52 NS
IHD 5 ischemic heart disease.
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formed the study population. Three hundred seventy-seven
episodes were recorded closer than 60 min to an initial
episode and were excluded from the main analysis. Hence,
1,061 episodes were included in the main analysis for
circadian variation.
Six hundred eighty-two episodes were recorded in the
ischemic heart disease group and 379 in the nonischemic
heart disease group. The median number of episodes in the
ischemic heart disease group was 2 (range 1 to 20) and 3
(range 1 to 18) in the nonischemic heart disease group,
respectively (NS). In the ischemic heart disease group, 39%
of the episodes were classified as ventricular tachycardia and
61% were classified as ventricular fibrillation episodes. The
corresponding figures in the nonischemic heart disease
group were 40% and 60%, respectively (NS).
Figure 1 shows the mean weighted distributions of
episodes, superimposed by the third-order harmonics. Both
circadian patterns reveal a morning peak at about 9 to 10 AM
and an afternoon peak at about 4 to 5 PM. The type I
configuration frequency analysis of first episodes revealed a
significant difference only in the frequencies of episodes
between 6 and 7 AM (multiple p 5 0.039) that was higher in
patients in the nonischemic group. There were no corre-
sponding differences in the adjacent time intervals and the
type II configuration frequency analysis did not reveal any
significant differences. Neither the hourly nor the four-
hourly circadian pattern was a significant predictor of
ischemia in a logistic regression model. Even percentages of
episodes falling into any of the defined time intervals did not
contribute significantly to the identification of patients with
ischemic heart disease. Patients receiving antiarrhythmic or
beta-blocker therapy did not show a different circadian
pattern compared with patients not receiving these medica-
tions.
Arrhythmia storms. One hundred nine patients experi-
enced arrhythmia storms, defined above. A total of 356
episodes was recorded during storms with a median number
of episodes of three (range 2 to 8) for each patient. Several
patients had more than one storm of episodes during the
follow-up period and the total number of storms was 156.
Seventy-two patients (35%) in the ischemic heart disease
group and 37 patients (35%) in the nonischemic heart
disease group experienced storms (NS).
Figure 2 shows the mean weighted distributions of
storms, superimposed by the third-order harmonics. Figure
2B reveals a distinct bimodality in patients with ischemic
heart disease, with a highly pronounced morning peak. In
patients with nonischemic heart disease, a more pronounced
afternoon peak was present.
Figure 1. Circadian distribution of the mean weighted frequencies of arrhythmic episodes for 310 patients. The bold line is the least
square fit of a third-order harmonic. (A) Patients with nonischemic heart disease. (B) Patients with ischemic heart disease.
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The type I and the type II configuration frequency
analysis of storms revealed no significant differences be-
tween patients with ischemic and nonischemic heart disease.
The smallest p value (0.135) was reached for the interval
between noon and 4 PM in which more storms occurred in
patients with ischemic heart disease. Although the hourly
circadian pattern was not significantly associated with isch-
emia in logistic regression, the 4-h circadian pattern just
missed significance (p 5 0.0795). If one includes the
percentage of storms that occur between noon and 4 PM into
a regression model, it is significantly associated with isch-
emia (p 5 0.0174). According to this model, the probability
that a patient who experiences all of his or her storms
between noon and 4 PM is a patient with nonischemic heart
disease is three times the probability of a patient who did
not experience any storm in the same interval.
DISCUSSION
The most important finding of our study was that the
circadian pattern of ventricular arrhythmias, detected by an
implantable cardioverter defibrillator, was not different in
patients with a history of ischemic heart disease compared
with patients with nonischemic heart disease. In both
groups, a typical circadian pattern was found with a morn-
ing, and less pronounced afternoon peak in the incidence of
ventricular arrhythmias. These results do not support the
hypothesis that, if ischemia plays an important role in the
triggering of ventricular arrhythmias, the circadian pattern
should be different in the two groups. The lack of difference
between the groups suggests that mechanisms other than
ischemia play the dominant role in the circadian variation of
ventricular arrhythmias.
Possible mechanisms underlying the circadian variation
of sudden death and ventricular arrhythmias. Several
mechanisms have been proposed to contribute to the circa-
dian rhythm found in sudden death and ventricular arrhyth-
mias. Many of these interact, making it difficult to delineate
the importance of each factor.
Sympathetic nervous system. The most widespread hy-
pothesis to explain the circadian pattern of cardiac adverse
events is a morning surge in sympathetic nerve activity
(26–28). It has been shown that the circadian rhythm of
cardiac neural regulation, using frequency domain measures
of the heart rate variability, has an unfavorable profile in the
morning hours (27,29–31). This could be caused by an
endogenous variation in the sympathetic tonus but could
also be a response to an increased activity level in the
morning hours, because strenuous physical exertion has
been shown to trigger ventricular arrhythmias (32). Evi-
Figure 2. Circadian distribution of the mean weighted frequencies of arrhythmia storms for 109 patients. The bold line is the least square
fit of a third-order harmonic. (A) Patients with nonischemic heart disease. (B) Patients with ischemic heart disease.
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dence to support this is the finding that beta-blocking
therapy reduces or eliminates the morning peak of ischemic
and arrhythmic events (10,33–36). Antiarrhythmic medica-
tion without beta-adrenergic blocking properties has not
been found to have the same effect (37). Moreover, plasma
norepinephrine level shows a prominent increase during the
morning hours and at the onset of daily activity (38).
According to data from patients with heart transplants, the
main triggering factor for ventricular arrhythmias may be
circulating catecholamines rather than effects mediated via
direct innervation (39).
Diurnal variation in electrophysiologic properties. Sev-
eral authors have studied the circadian variation of ventric-
ular refractoriness, either measured during an invasive elec-
trophysiologic study (40) or noninvasively by using the
telemetry function of permanent pacemakers (29,41). In all
studies, there was a consistent variation with the shortest
refractory periods during the awakening hours and the
longest during sleep. The maximal shortening of the refrac-
tory periods was observed around the hours of awakening.
Kong et al. (41) found that the time of the day was the only
independent predictor of ventricular refractory periods, and
other factors such as catecholamine levels and serum potas-
sium levels did not appear to influence the circadian
variation. These observations are in line with the diurnal
variation of maximal QT interval, in which a peak in QTc
and QTc variability in the morning hours has been found,
reflecting autonomic instability during this period (42).
Circadian variation of ischemic episodes. A circadian
variation with a peak incidence in the morning and in the
afternoon has been reported in several ischemia-related
conditions such as in myocardial infarction (9,36,43), angi-
nal attacks (44–46) and cerebrovascular stroke (47,48).
There is also evidence that this is closely linked to a diurnal
variation in the endothelial function (49) and biochemical
markers of thrombogenicity (50–54).
Arrhythmia storms. Myocardial ischemia may create a
transient substrate for ventricular arrhythmias (55). It may
therefore be expected that patients with ischemic heart
disease would have arrhythmia episodes (storms) more often
within a short time period compared with patients without
ischemia. We found, however, that the incidence of storms
was similar in the two groups. It is interesting to note that
the diurnal distribution of arrhythmia storms seems to be
different in the two study groups (Fig. 2). Although the
difference just missed statistical significance, the patients
with ischemic heart disease tended to have a more pro-
nounced morning peak and afternoon peak compared with
patients with nonischemic heart disease who had a more
even distribution. It can be speculated that this may be
caused by ischemic episodes occurring in the morning and
afternoon hours, as has been shown in previous studies on
the circadian variation of ischemic events (9,36,43).
Comparison with previous studies. The early studies on
circadian variation of ventricular arrhythmias and sudden
death used information from death certificates, interviews
with witnesses and long-term ECG recordings (1–3,10,11).
Although these studies had methodologic limitations, the
result was similar to later studies using information from
implantable cardioverter defibrillators (14–18). The use of
the storage capabilities of implantable cardioverter defibril-
lators represents an accurate tool for studying this issue. In
all but one of the previously reported studies on circadian
variation using information from implantable cardioverter
defibrillators, a morning peak between 10 and 12 AM and a
nadir between 2 and 5 AM were found (Table 2). Only very
few patients studied had nonischemic heart disease, making
it impossible to draw any firm conclusions regarding the
comparison of the groups of patients.
Statistical considerations. Harmonic analysis is a popular
method for analyzing circadian pattern in ventricular ar-
rhythmias (16,17,56). However, care has to be taken so that
the order of the fitted harmonic is chosen in a way that it
correctly describes the modes of the pattern. One-modal
harmonics will, in general, not be able to reveal the hidden
structure and may impose an artifact (17). In our data, a
third-order harmonic corresponding to an approximate 8-h
difference of distinct modes was adequate in most of the
analyses. Even after adequate choice of order, however,
there remain serious limitations with regard to harmonic
analysis: it is unable to cover the sharp rises and falls at the
beginning and end of daily activities, it does not rule out
Table 2. Previous Studies on Circadian Variation of Ventricular Arrhythmias in Which
Information From an Implantable Cardioverter Defibrillator Was Used
Study
No. of
Patients
No. of Patients
With Non-IHD (%) Peak Nadir
Wood et al. (17) 43 8 (19) 2–5 PM 2–3 AM
d’Avila et al. (15) 22 7 (32) 10–12 AM 3–6 AM
Mallavarapu et al. (16) 390 0 10–11 AM 2–3 AM
Behrens et al. (14) 39 12 (31) 8–11 AM 5–6 AM
Lampert et al. (56) 32 0 6–12 AM 3–4 AM
Behrens et al. (33) 87 34 (39) 6–11 AM 5–6 AM
Present study 310 106 (34) 7–10 AM 3–4 AM
IHD 5 ischemic heart disease.
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negative probabilities, and the symmetric error model of at
least squares fit obviously does not apply. Therefore, statis-
tical inference based on harmonic analysis is unreliable for
the circadian pattern of arrhythmias.
Some authors analyzed circadian patterns of recorded
episodes as if the episodes came from different patients,
resulting in high sample sizes if patients with frequent
episodes were included. Such an approach would be justified
only if repeated episodes in the same patient could be
regarded as stochastically independent. We used our data to
study this dependence structure. We found that in 56% of
the cases, a morning episode was followed by a morning
episode, while in 61% of the cases, an afternoon episode was
followed by an afternoon episode. Moreover, in 79% of the
cases, a morning storm was followed by a morning storm,
while in 61% of the cases, an afternoon storm was followed
by an afternoon storm. Both results differ significantly from
the independence assumption and are best explained by the
assumption that there exist types of patients with prefer-
ences for certain time intervals as has been suggested
previously (17,56). However, stochastic inference will pro-
duce false positive results if this dependence structure is
ignored. Therefore, any inferential analysis of circadian
pattern should use patients and not episodes as sampling
unit.
Configuration frequency analysis and logistic regression
modeling can be seen as two sides of a coin. One method
emphasizes rather local, the other rather global aspects.
Herein, the logistic model does not confirm the rather
spurious finding of a group difference at exactly 6 to 7 AM in
the configuration frequency analysis of hourly frequencies of
episodes. However, logistic regression can demonstrate the
apparent differences in the circadian patterns of storm
frequencies between patients with ischemic and nonisch-
emic heart disease better than the configuration frequency
analysis. However, only when we used the ex-post selected
interval of 12 to 16 h were we able to demonstrate
significant group differences in the circadian pattern of
storms. Therefore, the assumption of an association be-
tween the circadian distribution of storms and ischemia
remains hypothetical and requires independent validation.
One reason for our difficulty in demonstrating group
differences may be that with regard to the above demon-
strated dependence structure, the bimodal distributions in
Figures 1 and 2 are probably best understood as mixture
distributions, and ischemic and nonischemic populations
may differ only in the composition of different types of
patients. If this is true, only a clear identification of the type
a patient belongs to will help us to demonstrate group
differences due to ischemia, but this identification of types
possibly will require the observation of a higher number of
episodes per patient than could be observed in our popula-
tion. Future trials should be designed accordingly.
Study limitations. The two study groups differed signifi-
cantly in demographic characteristics and LV function,
which may have influenced the results. Ideally, the compar-
ison should be made with two well matched groups, but this
is probably not feasible because patients with ischemic and
nonischemic heart disease differ substantially, with the
former disease more common at higher age and in men. In
addition, it remains unclear whether the results of the study
may be generalized to other patient populations. For exam-
ple, patients with malignant ventricular tachyarrhythmias
during the acute phase of a myocardial infarction are not
included in the study because these patients are not candi-
dates for an implantable defibrillator. Furthermore, the
group of patients with nonischemic heart disease in the
present study was highly heterogeneous with regard to the
underlying cardiac disease. Thus, we cannot rule out that
certain groups of patients may perform a different pattern of
the circadian distribution of malignant arrhythmias.
In the present study, it was not possible to determine
whether the patients had ischemia before the episodes of
ventricular arrhythmia. Thus, in individual patients, the true
role of ischemia versus other triggering factors for the
initiation of ventricular tachyarrhythmias, such as an in-
creased sympathetic activity, remains unclear. However,
although the study did not show statistical differences of the
diurnal distribution of arrhythmias between groups, it may
be possible that myocardial ischemia plays a greater role in
individuals with ischemic heart disease. As mentioned
earlier, arrhythmic storms appear to show a distinct morn-
ing and afternoon peak in patients with ischemic heart
disease, whereas there was a more even distribution with a
slight afternoon peak in patients in the nonischemic group.
Thus, a greater number of arrhythmic storm episodes in
both groups are needed to prove whether the underlying
heart disease, and possibly myocardial ischemia, signifi-
cantly modifies the circadian variation of these arrhythmic
events.
Because the memory of these devices only stores infor-
mation on the time, date, type of ventricular arrhythmias,
and so forth from the five last episodes, this could have
influenced the result. However, a subgroup analysis, includ-
ing only patients in whom only full information of all
episodes was available, yielded the same results as the whole
group. It is not always possible to discriminate between
supraventricular and ventricular arrhythmias, even with
electrograms, but previous analysis suggests that the correct
diagnosis rate based on electrograms and intervals is high.
APPENDIX
The following investigators took part in the European 7219
Jewel ICD trial: E. Aliot, Nancy, J. M. Almendral, Madrid,
J. Amlie, Oslo, D. Andresen, Berlin, Y. Bashir, Oxford,
J. Ben-David, Haifa, M. Block, Mu¨nster, J. Brachmann,
Heidelberg, P. Brugada, Aalst, C. Bucknall, London,
A. J. Camm, London, R. Candinas, Zu¨rich, P. Coumel,
Paris, C. Cowan, Leeds, J.-C. Daubert, Rennes, D. W.
Davies, London, L. De Roy, Yvoir, K. den Dulk, Maas-
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tricht, S. Favale, Bari, S. Fischer, Augsburg, M. Fromer,
Lausanne, F. Furlanello, Trento, G. Gadaleta, Milano,
B. D. Gonska, Go¨ttingen, G. Grimm, Klagenfurt,
W. Grimm, Marburg, B. Grosch, Essen, H. Heuer, Dort-
mund, E. Hoffmann, Munich, R. Hofman, Linz, R. Ho¨lt-
gen, Duisburg, L. Jordaens, Gent, W. Jung, Bonn, A. Katz,
Beer Sheba, W. Klein, Graz, V. Ku¨hlkamp, Tu¨bingen,
B. Lemke, Bochum, C. Menozzi, Reggio Emilia, C. Moro
Serrano, Madrid, N. Muzika, Vienna, J. Nesser, Linz,
I.W.P. Obel, Johannesburg, O.-J. Ohm, Bergen, C. Pap-
pone, Napoli, V. Paul, Uxbridge, A. Pietersen, Kopenha-
gen, A. Pisapia, Marseille, A. Podczeck, Vienna, J. Potratz,
Lu¨beck, P. Ricard, Marseille, M. Rosenqvist, Stockholm,
P. Scanu, Caen, A. Schirdewan, Berlin, H. Schmidinger,
Vienna, C. Schmitt, Munich, K. Seidl, Ludwigshafen,
J. Siebels, Hamburg, J. D. Skehan, Leicester, C. Stellbrink,
Aachen, P. Touboul, Lyon, H. J. Trappe, Hannover,
Tro¨ster, Oldenburg, B. Waldecker, Giessen, A. Waleffe,
Lie`ge, K. Walsh, Liverpool, B. Wille, Kiel
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